Gabapentin and Pregabalin for the Treatment of Anxiety Disorders

Clin Pharmacol Drug Dev. 2018 Mar;7(3):228-232. doi: 10.1002/cpdd.446.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Anxiety Agents / chemistry
  • Anti-Anxiety Agents / therapeutic use*
  • Anxiety Disorders / diagnosis
  • Anxiety Disorders / drug therapy*
  • Anxiety Disorders / psychology
  • GABA Agents / chemistry
  • GABA Agents / therapeutic use
  • Gabapentin / chemistry
  • Gabapentin / therapeutic use*
  • Humans
  • Pregabalin / chemistry
  • Pregabalin / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Anxiety Agents
  • GABA Agents
  • Pregabalin
  • Gabapentin